Skip to Content

WPI 2264 (Acitretin 17.5 mg)

Pill with imprint WPI 2264 is Yellow, Capsule-shape and has been identified as Acitretin 17.5 mg. It is supplied by Actavis Pharma, Inc..

Acitretin is used in the treatment of psoriasis and belongs to the drug class antipsoriatics. Not for use in pregnancy. Acitretin 17.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2264

Acitretin

Imprint
WPI 2264
Strength
17.5 mg
Color
Yellow
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antipsoriatics
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00591-2264
Inactive Ingredients
maltodextrin, sodium ascorbate, microcrystalline cellulose, gelatin, sodium lauryl sulfate, titanium dioxide, ferric oxide yellow, shellac, ferrosoferric oxide, propylene glycol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.